@article{11195,
  keywords = {Humans, *Idiopathic Pulmonary Fibrosis/epidemiology/mortality/diagnosis, Male, Female, Aged, *Comorbidity, Middle Aged, *Pulmonary Disease, Chronic Obstructive/epidemiology/diagnosis/mortality, Prevalence, Aged, 80 and over, Cohort Studies, Incidence, chronic obstructive pulmonary disease, Comorbidities, Idiopathic pulmonary fibrosis},
  author = {B. Ozaltin and R. Chapman and M. Arfeen and N. Fitzpatick and H. Hemingway and K. Direk and J. Jacob},
  title = {Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study},
  year = {2024},
  journal = {Respir Res},
  volume = {25},
  edition = {2024/06/20},
  number = {1},
  pages = {249},
  isbn = {1465-9921 (Print)
1465-9921},
  doi = {10.1186/s12931-024-02875-2},
  note = {1465-993x
Ozaltin, Burcu
Chapman, Robert
Arfeen, Muhammad Qummer Ul
Fitzpatick, Natalie
Hemingway, Harry
Direk, Kenan
Jacob, Joseph
[209553/Z/17/Z]/WT_/Wellcome Trust/United Kingdom
Journal Article
Observational Study
England
Respir Res. 2024 Jun 19;25(1):249. doi: 10.1186/s12931-024-02875-2.},
  language = {eng},
}